Ronald Bates

Ronald Bates, Ph.D. is the Vice President of CMC Process Development and Technical Operations at Immunovant. Prior to joining Immunovant, Ron was a Director of Manufacturing Science and Technology (MSAT) at Bristol-Myers Squibb in Syracuse, NY where he was part of the development and commercialization of numerous protein therapeutics. Dr. Bates has more than 20 years of experience in the biopharmaceutical industry holding roles of increasing responsibility in Process Development and MSAT with Pfizer, Allergan, and Bristol-Myers Squibb. He is active in the scientific community with over 50 publications and presentations, chaired dozens of conference sessions and roundtable discussions, and he is a member of the Editorial Board of the Biotechnology Journal.

Dr. Bates earned a B.S. in Chemical Engineering from Rensselaer Polytechnic Institute and a Ph.D. in Biochemical Engineering from the University of Maryland, Baltimore County.